| MeSH term | MeSH ID | Detail |
|---|---|---|
| Foreign-Body Reaction | D005549 | 10 associated lipids |
| Lymphoma, T-Cell | D016399 | 11 associated lipids |
| Congenital Abnormalities | D000013 | 11 associated lipids |
| Eye Diseases | D005128 | 12 associated lipids |
| Glucose Intolerance | D018149 | 13 associated lipids |
| Hypoglycemia | D007003 | 13 associated lipids |
| Thymus Neoplasms | D013953 | 15 associated lipids |
| Neutropenia | D009503 | 15 associated lipids |
| Tongue Neoplasms | D014062 | 15 associated lipids |
| Thrombocytopenia | D013921 | 15 associated lipids |
CYTOCHALASIN B
CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.
Cross Reference
Introduction
To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with CYTOCHALASIN B?
CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B
PubChem Associated disorders and diseases
What pathways are associated with CYTOCHALASIN B
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with CYTOCHALASIN B?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with CYTOCHALASIN B?
Related references are published most in these journals:
- Am. J. Physiol., Cell Physiol. (2)
- Am. J. Physiol. Endocrinol. Metab. (1)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Others (8)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with CYTOCHALASIN B?
Xenograft Model
Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with CYTOCHALASIN B
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Somfai T et al. | Development to the blastocyst stage of parthenogenetically activated in vitro matured porcine oocytes after solid surface vitrification (SSV). | 2006 | Theriogenology | pmid:16464491 |
| Chen N et al. | Early development of reconstructed embryos after somatic cell nuclear transfer in a non-human primate. | 2006 | Theriogenology | pmid:16701816 |
| Davis RB | Proceedings: Effects of aggregating agents, cytochalasin B (CB) and neuraminidase (N) on the ultrastructure of freeze dried (FD) human blood platelets. | 1975 | Thromb Diath Haemorrh | pmid:1198451 |
| Kirkpatrick JP et al. | Differential effects of cytochalasin B on platelet release, aggregation and contractility: evidence against a contractile mechanism for the release of platelet granular contents. | 1980 | Thromb. Haemost. | pmid:6892735 |
| Prydz H and Allison AC | Tissue thromboplastin activity of isolated human monocytes. | 1978 | Thromb. Haemost. | pmid:705686 |
| Jeleńska M and Kopeć M | Blood platelets cause retraction of collagen gel. | 1980 | Thromb. Haemost. | pmid:6781097 |
| Peerschke EI and Zucker MB | Relationship of ADP-induced fibrinogen binding to platelet shape change and aggregation elucidated by use of colchicine and cytochalasin B. | 1980 | Thromb. Haemost. | pmid:7404479 |
| Morimoto K et al. | Role of urokinase type plasminogen activator (u-PA) in corneal epithelial migration. | 1993 | Thromb. Haemost. | pmid:8497852 |
| Muñoz-Cánoves P et al. | Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro. | 1997 | Thromb. Haemost. | pmid:9066006 |
| Misselwitz F et al. | Substances that polymerize or depolymerize cytoskeletal proteins affect platelet spreading and thrombus-formation on surfaces coated with human collagen isotypes I, IV, and V. | 1988 | Thromb. Res. | pmid:3413723 |
| Patscheke H and Wörner P | Sequential effects of the thiol-oxidizing agent, diamide, on human platelets. | 1978 | Thromb. Res. | pmid:663899 |
| Rendu F and Lebret M | Interaction of wheat germ agglutinin with human platelets: a model for studying platelet response. | 1984 | Thromb. Res. | pmid:6441308 |
| Haslam RJ and Lynham JA | Relationship between phosphorylation of blood platelet proteins and secretion of platelet granule constituents II. Effects of different inhibitors. | 1978 | Thromb. Res. | pmid:208190 |
| van Gelder JM et al. | Platelets and the permeability of fibrin network developed in human plasma. | 1993 | Thromb. Res. | pmid:8303674 |
| Markosian RA and Kozlov VK | A study of transformations of blood platelets intracellular granules during clot formation by means of fluorescent marker method. | 1980 | Thromb. Res. | pmid:7189908 |
| Patscheke H et al. | The relationship between shape change and release reaction of lectin-stimulated platelets. Effects of cytochalasin B and prostaglandin E1. | 1977 | Thromb. Res. | pmid:854880 |
| Mitsui-Saito M et al. | Theonezolide A, a novel marine macrolide, induces drastic shape change in rabbit platelets by reorganization of microtubules. | 2002 | Thromb. Res. | pmid:12590949 |
| Goto S et al. | Thrombin-induced shape change in human megakaryoblastic leukemic cells, MEG-01, is mediated by protein kinase C. | 1992 | Thromb. Res. | pmid:1448800 |
| Patscheke H and Wörner P | Common activation of aggregation and released reaction of platelets. | 1977 | Thromb. Res. | pmid:411193 |
| Patscheke H and Wörner P | Platelet activation detected by turbidometric shape-change analysis: differential influence of cytochalasin B and prostaglandin E1. | 1978 | Thromb. Res. | pmid:418518 |